A Multicenter Phase 3, Randomized Comparison of the Safety and Efficacy of Weekly TOCOSOL(R) Paclitaxel vs. Weekly Paclitaxel Injection in the Treatment of Metastatic Breast Cancer
Phase of Trial: Phase III
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors OncoGenex Pharmaceuticals
- 09 Apr 2014 Pharmacokinetic results presented at the 105th Annual Meeting of the American Association for Cancer Research.
- 17 Nov 2008 Actual patient number identified as 821 from ClinicalTrials.gov.
- 17 Nov 2008 Actual trial completion date identified as September 2007 from ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History